Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction

AIMS: Ivabradine and sacubitril/valsartan are second‐line therapies for patients with heart failure and reduced ejection fraction (HFrEF) based on guideline recommendations. We aimed to evaluate the synergistic effects of these two medications. METHODS AND RESULTS: Patients' data were extracted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ESC Heart Fail
Hauptverfasser: Lee, Ying‐Hsiang, Lin, Po‐Lin, Chiou, Wei‐Ru, Huang, Jin‐Long, Lin, Wen‐Yu, Liao, Chia‐Te, Chung, Fa‐Po, Liang, Huai‐Wen, Hsu, Chien‐Yi, Chang, Hung‐Yu
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2021
Schlagworte:
Original Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006660/
https://ncbi.nlm.nih.gov/pubmed/33410280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13182
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge